Clinical Trials

Pneumococcal Vaccine

Posted on 6/7/2019
This is a research study to test a vaccine that has not been approved for sale by the FDA.  The vaccine is being studied to protect against pneumococcal disease. The purpose of this study is to test the safety of the study vaccine to see how well the vaccine works when given at the same time as other recommended childhood vaccines. 

Your child would receive either the pneumococcal study vaccine or Prevar 13, which is already approved.  Your child will receive the vaccine at 2, 4, 6, 12 and 15 months of age.  In addition, your child will receive all the other normal vaccinations (RotaTeq, RECOMBIVAX HB, Pentacel, HIBERIX, M-M-R II, VARIVAX, VAQTA)

Your child may be able to join this study if your child is a healthy infant about 2 months old.

Your child will be in the study about 16-20 months and visit the study site about 6 times.

All study visits, procedures and study vaccinations will be provided at no cost to you or your insurance company. 

In addition, you will be compensated for your time and travel if you decide to allow your child participate.  If you and your child complete the study, you will receive up to $510.00.

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
"Last January I had to begin taking insulin for my diabetes. It was life changing for me. I had always been afraid of starting insulin. However, when I qualified for the diabetes clinical trial, it helped me accept this change in my life. The Research Coordinators are the very best you could ask for. They explained everything and let me know what to expect. I could never have controlled my diabetes if it hadn't been for this research program, the research staff and the study doctor. I would recommend participating in a research trial to anyone who has diabetes. It and the research staff are a godsend."
~ C.D

Contact Form

DCOL of Longview